[48] developed panels targeting patient-specific KIT and PDGFRa mutations in GIST patients, termed “simple multiplexed PCR-based barcoding of DNA for sensitive mutation detection using sequencing” (SiMSen-Seq). This evidence concerns the gene KIT and gastrointestinal stromal tumor.